Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes.

Giacinto TrioloJing WangSoledad Aguilar-MunoaHari JayaramKeith Barton

Published in: Eye (London, England) (2022)

Three-year results of the PRESERFLO Microshunt implant demonstrated favourable efficacy and safety profile in the treatment of refractory uveitic glaucoma.

Keyphrases

type diabetes
soft tissue
metabolic syndrome
adipose tissue
insulin resistance
weight loss
glycemic control